Who Created this Site?
The MTC CoRe (Medullary Thyroid Cancer Collaborative Registry) Consortium is a collaboration initiated in 2011 by the University of Texas MD Anderson Cancer Center and later further established by partnering with the University of California San Francisco. The mission of the consortium is for stakeholders to unite around advancing the patient-centered science with regards to this rare disease. Stakeholders include researchers, patients, caregivers, healthcare providers, patient support organizations, professional organizations and industry partners.
Below are members of the consortium who created the content for this site.
Elizabeth Grubbs, MD
Her clinical practice is dedicated to the treatment of benign and malignant endocrine disease. Clinical and research interests focus on the treatment of hereditary endocrine neoplasias and sporadic medullary thyroid cancer. She led the team that founded The MTC CoRe (Medullary Thyroid Cancer Collaborative Registry) Consortium and has current federal funding to evaluate natural history well as patient reported outcomes of this often chronic disease. She Is a member of the International Thyroid Oncology Group and a member of the adviosry board for ThyCa and AMENDSupport.
Mimi Hu, M.D.
Anne Brinkman, APRN
Maria E. Cabanillas, M.D.
Maria E. Cabanillas, M.D. is an Oncologic Endocrinologist at the University of Texas MD Anderson Cancer Center in Houston, Texas where she is a Professor and the Faculty Director of Clinical Research in the Department of Endocrine Neoplasia and Hormonal Disorders.
As a clinician and clinical researcher, she focuses her practice on both early and advanced thyroid cancers, including medullary, differentiated, and anaplastic thyroid cancers. Her research focus is in advanced and aggressive thyroid cancer, with an emphasis that includes molecular targeted therapies and immunotherapy. Dr. Cabanillas serves as the principal investigator on several clinical trials for the treatment of advanced thyroid cancer. She has been a member of the International Thyroid Oncology Group (ITOG) since 2012 .
Julie Ann Sosa, MD MA FACS
Steven G. Waguespack, MD
Mark Zafereo, M.D., F.A.C.S.
The creators and contributors would like to thank research staff members Danielle Shojaie, Ruth Amaku and Shanae Speller for their hard work on the creation of this website. They also would like to thank the MTC patients and their families who entrust themselves to our care, many of whom contributed to the creation of this website with their ideas and feedback. They have our deepest gratitude.